Anthropic’s much-awaited move to go public is running into pushback from investors. Reports indicate the AI lab could push back its IPO and lower its valuation goal to around $1 trillion as tech stocks slide. That shift points to a deeper change in how markets view the AI sector: buyers now want clearer proof of margins, governance, and partner ties before they fund the heavy compute bills that come with training frontier models.
Quick Take
- What happened: Anthropic is reportedly considering a delayed roadshow and a reduced valuation target of $1 trillion, stepping down from earlier discussions that reached up to $2 trillion.
- Why it matters now: A multi-trillion-dollar rout in AI stocks is forcing a reckoning on LLM economics, demanding that frontier labs justify historical revenue multiples that dwarf past tech IPOs.
- Who is most affected: Retail and institutional investors eyeing the anticipated “ANT” ticker, alongside rival AI labs closely watching how public markets value high-compute business models.
- The under-reported angle: Anthropic’s complex web of compute dependencies and financial partnerships with hyperscalers like Amazon and Google introduces structural margin risks that its S-1 filing has yet to fully resolve.
What happened
The road to public markets for the team behind Claude has hit a snag. A roughly $3 trillion drop across tech stocks, plus growing skepticism from institutions about untested AI economics, has led Anthropic to rethink a November launch. People close to the talks say the company may now aim for a $1 trillion valuation instead of the $1.5–2 trillion range floated earlier.
Wall Street is still studying the gaps in the S-1. Pricing and governance details remain open, and banks are resisting the high entry price needed to back the frontier-AI story. Even at the lower target, buyers would pay 76–101 times trailing revenue—far above Google’s 16x multiple in 2004.
Why it matters now
Anthropic’s listing will test whether the frontier-AI model can stand on its own. Private funding and hyperscaler deals have shielded labs from public scrutiny so far. Once shares trade, the real costs surface: huge data-center outlays, constant demand for new chips, and long-term cloud contracts.
If investors balk at the asking price, the signal will travel through the whole stack. It would show that public money for capital-heavy AI has limits, especially when labs depend on the same cloud giants that both invest in them and sell them compute. A trimmed but completed IPO would also shape how OpenAI and others time their own moves.
Who is most affected
The effects reach past individual investors hoping to buy “ANT” on the Nasdaq. Venture firms, cloud providers swapping compute for equity, and chip makers counting on steady scaling all feel the change.
| Stakeholder | Impact | Why |
|---|---|---|
| Frontier AI Labs | Benchmark recalibration | Competitors like OpenAI will see their private valuations stress-tested against Anthropic’s public market reception. |
| Hyperscalers (Amazon/Google) | Compute debt scrutiny | Their dual role as primary investors and sole compute providers will face intense regulatory and market examination. |
| Retail Investors | Delayed access & volatility | The delayed listing and complex share class structures elevate the risk profile for non-institutional buyers looking to enter the AI space. |
The compute and control dilemma
The hesitation is not only about market swings. It reflects a deeper issue with how these labs are built. Anthropic needs nonstop, expensive scaling to keep Claude competitive, which ties it tightly to its cloud partners. Unless revenue grows much faster than those fixed compute costs, profits stay hard to reach. At the same time, open questions about governance highlight the clash between a public-benefit mission centered on safety and the short-term growth pressure that comes with being public.
About the analysis
Researched and written with AI assistance under the editorial responsibility of the i10X News team. The title image is an AI-generated illustration. Read our AI Use Policy. Spotted an error? Request a correction.
This independent i10x analysis maps the intersection of financial markets and AI infrastructure, designed for founders, CTOs, and tech investors tracking the economics of foundational models.
- EXCLUSIVE: AI backlash could threaten Anthropic IPO timing, potential investors say
- Anthropic IPO Valuation Could Fall to $1 Trillion, May Delay: Report
- Anthropic IPO: The big questions its S-1 leaves unanswered
- Anthropic IPO: What We Know About Its Forthcoming Stock Market Debut
- Is Anthropic’s IPO A Worse Bet Than Google’s?
- What to Know Ahead of Anthropic’s IPO (NASDAQ: ANT)
i10x Perspective
The tension around Anthropic’s IPO is not a technology problem; it is the point where ambitious AGI forecasts meet the hard numbers of public markets. While intelligence still depends on costly, hyperscaler-controlled compute, these labs will find it difficult to prove they are independent, high-margin businesses rather than elaborate loss leaders for the big cloud providers. We may be witnessing the end of the AI blank check.
